Evidence map›Paper›PMID 35956350›Full record

ArticleNutrients2022

Elucidation of Anti-Hypertensive Mechanism by a Novel

Haicui Wu, Lilong Jiang, Tim-Fat Shum, Jiachi Chiou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Nutrients · 2025
    Article
  3. Review
  4. Review
  5. Bioactive Peptides fromMolecules (Basel, Switzerland) · 2023
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Haicui WuShenzhen Key Lab for Food Biological Safety Control, Hong Kong PolyU Shen Zhen Research Institute, Shenzhen 518000, China.
Lilong JiangDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China.
Tim-Fat ShumDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China.ORCID 0000-0002-4149-2983
Jiachi ChiouShenzhen Key Lab for Food Biological Safety Control, Hong Kong PolyU Shen Zhen Research Institute, Shenzhen 518000, China.ORCID 0000-0001-8306-1826
Hong Kong Polytechnic University · HK

Funding

Health and Medical Research Fund 15161391
6 · The paper itself

Abstract

Dietary intake of fermented soymilk is associated with hypotensive effects, but the mechanisms involved have not been fully elucidated. We investigated the anti-hypertensive effects of soymilk fermented by

Indexed as

Desoxycorticosterone AcetateHypertensionLacticaseibacillus rhamnosusAcetatesAnimalsAntihypertensive AgentsBlood PressureDesoxycorticosteroneRatsAcetatesAntihypertensive AgentsDesoxycorticosteroneDesoxycorticosterone Acetatefermented soymilkgut microbiotahypertensionL. rhamnosus AC1

Identifiers

PMID35956350
PMCPMC9370603
OpenAlexW4289522859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.